How should an osteochondroma in an adolescent or young adult be evaluated and managed?

Osteochondroma in Adolescents and Young Adults: Evaluation and Management

For an adolescent or young adult with an osteochondroma, begin with annual physical examinations to monitor for pain or rapid growth, obtain baseline imaging around age 12 years (preferably whole-body MRI or plain radiographs), and pursue immediate MRI/CT with consideration of biopsy if the cartilage cap exceeds 2.0 cm, the lesion shows rapid growth, or new pain develops 1.

Initial Evaluation

Clinical Assessment

Perform annual physical examinations starting from diagnosis, specifically evaluating for:

• New or increasing pain (most concerning sign for malignant transformation)
• Rapid lesion growth (particularly after skeletal maturity)
• Mechanical symptoms (catching, locking, or restricted range of motion)
• Neurological symptoms if spinal involvement (compressive myelopathy can occur) 2
• Functional limitations or deformities (angular deformities, leg length discrepancy, short stature) 1

Baseline Imaging Strategy

At early adolescence (around 12 years):

• Obtain baseline skeletal survey when most osteochondromas have evolved but before peak transformation risk
• Preferred modality: Whole-body MRI (WBMRI) 1
• Alternative if WBMRI unavailable: Plain radiographs 1
• This timing captures lesion burden before the age of malignant transformation risk (which peaks between 20-40 years) 1

Initial Imaging for Suspected Lesion

For a newly identified suspected osteochondroma:

• Start with plain radiographs of the area of interest for detection and characterization 3
• If radiographs show a benign-appearing lesion, MRI may be useful for surgical planning or assessing fracture risk 3

Risk Stratification for Malignant Transformation

Understanding the Risk

• Solitary osteochondromas: Malignant transformation to chondrosarcoma occurs in <1% of cases 4
• Hereditary Multiple Osteochondromas (HMO): Transformation risk is 0.2% to 5.9%, with higher risk in males and EXT1 mutation carriers 1
• Transformation typically occurs between ages 20-40 years, but can occur as early as 9-13 years 1

High-Risk Features Requiring Immediate Advanced Imaging

Obtain MRI or CT immediately if any of the following are present:

• Cartilage cap thickness >2.0-3.0 cm on imaging 1
• Rapid growth of the lesion 1
• New or increasing pain (though note: pain can occur with benign lesions and some chondrosarcomas are asymptomatic) 1
• Lesion location in pelvis or scapula (higher transformation rates) 1

High-Risk Anatomic Locations

Lesions in these locations warrant more intensive surveillance:

• Pelvis and scapula: Consider regional MRI every 2-3 years from identification, particularly in males or EXT1 carriers 1
• Spine: Spinal osteochondromas affect up to 68% of HMO patients and can cause compressive myelopathy; consider screening MRI 5, 2

Surveillance Protocol

For Solitary Osteochondromas

• Annual physical examination monitoring for pain, growth, or functional changes 1
• No routine imaging of all known lesions (due to low transformation risk) 1
• Targeted imaging only if concerning clinical features develop 1

For Hereditary Multiple Osteochondromas (HMO)

• Annual physical examination from birth 1
• Baseline WBMRI at early adolescence (around 12 years) 1
• Periodic WBMRI after age 20 years (when transformation risk increases) 1
• Regional MRI every 2-3 years for pelvic/scapular lesions, especially in males or EXT1 carriers 1
• Do NOT perform routine plain films of all known lesions (high lesion burden makes this impractical) 1

Management Decisions

When to Observe

• Asymptomatic lesions with benign radiographic features
• Cartilage cap <2.0 cm on imaging
• No growth after skeletal maturity
• No high-risk anatomic location concerns

When to Consider Surgical Excision

Indications for surgery:

• Symptomatic lesions causing pain or mechanical symptoms 6
• Cartilage cap ≥2.0 cm (consider tissue diagnosis) 1
• Rapid growth or increasing pain 1
• Functional impairment or deformity requiring correction 6
• Neurological symptoms from spinal lesions 5, 2

Surgical outcomes: In a large pediatric series, 96% returned to sports at median 2.5 months, with only 2% experiencing major complications and 1.1% recurrence rate 6. Sessile lesions, younger age, and distal femoral location carry higher complication risk 6.

Critical Pitfalls to Avoid

1. Don't dismiss pain as benign: While pain can occur with benign lesions, it's the most common presenting symptom of malignant transformation 1

2. Don't rely solely on imaging: Some chondrosarcomas are asymptomatic, and conversely, benign lesions can be painful 1

3. Don't forget spinal screening in HMO: 36% of HMO patients have spinal osteochondromas, with 49% being intraspinal and 21% requiring surgery 5

4. Don't stop surveillance at skeletal maturity: Osteochondromas should stop growing after puberty; continued growth suggests malignant transformation 1

5. Don't perform routine imaging of all lesions in HMO: The high lesion burden and low transformation rate make this impractical; focus on clinical examination and high-risk locations 1

Orthopedic Involvement

Orthopedic providers should be involved in monitoring all osteochondromas, particularly for surgical planning and management of complications 1.